Technological Innovation, Authority Reaffirmed! Medicilon was awarded the "2023 Shanghai Science and Technology Little Giant Enterprise"

Recently, the Shanghai Science and Technology Commission officially issued the "Notice on the Announcement of the List of 2023 Shanghai Science and Technology Little Giants (Including Cultivation) Enterprises".   Medicilon Preclinical Research (Shanghai) LLC (MPR), a subsidiary of Medicilon, was recognized as one of the 2023 Shanghai Science and Technology Little Giants Company.  This is the second time Medicilon has received this honorary title.

About Shanghai Science and Technology Little Giant

The Shanghai Science and Technology Little Giant Project is jointly promoted by the Shanghai Science and Technology Commission, the Municipal Economic and Information Technology Commission, and the Municipal Finance Bureau.  It aims to deeply implement the innovation-driven development strategy, accelerate the construction of a technological innovation center with global influence, and create a large number of small technological giant enterprises with competitive advantages in domestic and foreign industries.  The entire project has gone through public declaration, strict review and recommendation, authoritative expert review and publicity procedures, which is extremely fair and authoritative.